Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Jan 24, 2019
Document Date
Jan 23, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
Cohen Fred E